I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 498.2 ILS -5.46% Market Closed
Market Cap: 239.6m ILS
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InterCure Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
TASE:INCR
Cash from Financing Activities
-â‚Ş82.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Cash from Financing Activities
-$2.3B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
0%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Cash from Financing Activities
$90k
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Cash from Financing Activities
-$1.7m
CAGR 3-Years
-31%
CAGR 5-Years
-77%
CAGR 10-Years
N/A
S
Seach Medical Group Ltd
TASE:SEMG
Cash from Financing Activities
-â‚Ş3.4m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Cash from Financing Activities
-â‚Ş55m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

InterCure Ltd
Glance View

Market Cap
239.6m ILS
Industry
Pharmaceuticals

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

INCR Intrinsic Value
1 796.79 ILS
Undervaluation 72%
Intrinsic Value
Price
I

See Also

What is InterCure Ltd's Cash from Financing Activities?
Cash from Financing Activities
-82.9m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Cash from Financing Activities amounts to -82.9m ILS.

Back to Top